Journal article
Thiazide Diuretics: 50 Years and Beyond
Current hypertension reviews, Vol.4(4), pp.256-265
01/01/2008
DOI: 10.2174/157340208786241264
Abstract
Since the introduction of chlorothiazide into clinical practice in 1958, thiazide-type diuretics have weathered decades of criticism and controversy. Fifty years later, they remain the single most important class of antihypertensives available. Numerous clinical trials across broad populations consistently demonstrate superior reductions in cardiovascular outcomes with thiazide-based regimens and most notably using the thiazide-like diuretic, chlorthalidone. Recent evidence suggests there may be important differences among thiazides that favor chlorthalidone due to its longer half-life and duration of action. Despite their proven record, thiazide diuretics continue to be scrutinized for their well-known adverse metabolic profile, especially hypokalemia. Glucose intolerance and incident diabetes with diuretic therapy has received significant attention; however, evidence from the ALLHAT study and others indicate the reductions in cardiovascular outcomes with thiazides are also observed in diabetics. Potassium depletion may be associated with diuretic dysglycemia. To minimize the adverse metabolic profile of thiazides, clinicians should preferentially use low doses. Combinations with potassium-sparing agents, or with renin-angiotensin system drugs such as angiotensin-converting enzyme inhibitors or angiotensin receptor blockers should also be considered. The last fifty years has seen remarkable advances in our understanding and treatment of hypertension and thiazides remain the most important pharmacologic advancement in our therapy of hypertension.
Details
- Title: Subtitle
- Thiazide Diuretics: 50 Years and Beyond
- Creators
- Michael E. Ernst - Univ Iowa, Coll Pharm, Div Clin & Adm Pharm, Iowa City, IA 52242 USARichard H. Grimm - Univ Minnesota, Berman Ctr Outcomes & Clin Res, Minneapolis Med Res Fdn, Minneapolis, MN 55455 USA
- Resource Type
- Journal article
- Publication Details
- Current hypertension reviews, Vol.4(4), pp.256-265
- Publisher
- Bentham Science Publ Ltd
- DOI
- 10.2174/157340208786241264
- ISSN
- 1573-4021
- eISSN
- 1875-6506
- Number of pages
- 10
- Language
- English
- Date published
- 01/01/2008
- Academic Unit
- Pharmacy Practice and Science; Family Medicine
- Record Identifier
- 9984297454902771
Metrics
4 Record Views